Royal Mail (OTCMKTS:ROYMY – Get Rating) had its price objective lowered by equities research analysts at UBS Group from GBX 540 ($7.03) to GBX 420 ($5.46) in a research note issued on Wednesday, The Fly reports.
A number of other analysts have also recently issued reports on ROYMY. Deutsche Bank Aktiengesellschaft cut Royal Mail from a “buy” rating to a “sell” rating in a research report on Tuesday, March 29th. Credit Suisse Group cut Royal Mail from a “neutral” rating to an “underperform” rating in a research report on Thursday, March 3rd. Zacks Investment Research cut Royal Mail from a “buy” rating to a “sell” rating in a research report on Friday, March 25th. Finally, JPMorgan Chase & Co. decreased their price target on Royal Mail from GBX 708 ($9.21) to GBX 702 ($9.13) in a research note on Thursday, March 17th. Three equities research analysts have rated the stock with a sell rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat, Royal Mail currently has an average rating of “Hold” and a consensus target price of $365.50.
Shares of OTCMKTS ROYMY traded down $0.01 during trading hours on Wednesday, reaching $8.94. The stock had a trading volume of 11,692 shares, compared to its average volume of 5,129. Royal Mail has a fifty-two week low of $8.53 and a fifty-two week high of $17.05. The firm has a 50-day moving average of $9.82 and a 200-day moving average of $11.66.
Royal Mail Plc engages in the provision of postal and delivery services. It operates through the following segments: Royal Mail and General Logistics Systems (GLS). The Royal Mail segment collects, sorts and delivers letters and parcels across the UK. The GLS segment operates in continental Europe and the Republic of Ireland and has a ground-based deferred parcel delivery network in Europe.
- Get a free copy of the StockNews.com research report on Royal Mail (ROYMY)
- Highly Valued Abbot Laboratories Could Move Lower
- Baker Hughes, Another Buy-The-Dip Opportunity In Oilfield Services
- Netflix (NASDAQ: NFLX) Falls Back to 2018 Levels
- Is Turning Point Therapeutics Stock at a Turning Point?
- Buy Haliburton On Post-Earnings Weakness
Receive News & Ratings for Royal Mail Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Royal Mail and related companies with MarketBeat.com's FREE daily email newsletter.